Viewing Study NCT00227760


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-25 @ 7:26 AM
Study NCT ID: NCT00227760
Status: COMPLETED
Last Update Posted: 2016-02-29
First Post: 2005-09-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery
Sponsor:
Organization: